GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chimerix Inc (STU:CXF) » Definitions » Cyclically Adjusted FCF per Share

Chimerix (STU:CXF) Cyclically Adjusted FCF per Share : €-1.33 (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Chimerix Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Chimerix's adjusted free cash flow per share for the three months ended in Jun. 2024 was €-0.184. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-1.33 for the trailing ten years ended in Jun. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-09-25), Chimerix's current stock price is €0.725. Chimerix's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 was €-1.33. Chimerix's Cyclically Adjusted Price-to-FCF of today is .


Chimerix Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Chimerix's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chimerix Cyclically Adjusted FCF per Share Chart

Chimerix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -1.21 -1.33 -1.22

Chimerix Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.34 -1.37 -1.22 -1.24 -1.33

Competitive Comparison of Chimerix's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Chimerix's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chimerix's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chimerix's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Chimerix's Cyclically Adjusted Price-to-FCF falls into.



Chimerix Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chimerix's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.184/132.5538*132.5538
=-0.184

Current CPI (Jun. 2024) = 132.5538.

Chimerix Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 -0.258 100.428 -0.341
201412 -0.356 99.070 -0.476
201503 -0.425 99.621 -0.565
201506 -0.505 100.684 -0.665
201509 -0.494 100.392 -0.652
201512 -0.671 99.792 -0.891
201603 -0.561 100.470 -0.740
201606 -0.247 101.688 -0.322
201609 -0.254 101.861 -0.331
201612 -0.200 101.863 -0.260
201703 -0.274 102.862 -0.353
201706 -0.247 103.349 -0.317
201709 -0.203 104.136 -0.258
201712 -0.219 104.011 -0.279
201803 -0.316 105.290 -0.398
201806 -0.252 106.317 -0.314
201809 -0.230 106.507 -0.286
201812 -0.144 105.998 -0.180
201903 -0.275 107.251 -0.340
201906 -0.240 108.070 -0.294
201909 -0.655 108.329 -0.801
201912 -0.051 108.420 -0.062
202003 -0.159 108.902 -0.194
202006 -0.113 108.767 -0.138
202009 -0.114 109.815 -0.138
202012 -0.119 109.897 -0.144
202103 -0.398 111.754 -0.472
202106 -0.124 114.631 -0.143
202109 -0.151 115.734 -0.173
202112 -0.347 117.630 -0.391
202203 -0.244 121.301 -0.267
202206 -0.114 125.017 -0.121
202209 0.082 125.227 0.087
202212 -0.214 125.222 -0.227
202303 -0.236 127.348 -0.246
202306 -0.150 128.729 -0.154
202309 -0.190 129.860 -0.194
202312 -0.150 129.419 -0.154
202403 -0.181 131.776 -0.182
202406 -0.184 132.554 -0.184

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Chimerix  (STU:CXF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Chimerix Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Chimerix's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Chimerix Business Description

Industry
Traded in Other Exchanges
Address
2505 Meridian Parkway, Suite 100, Durham, NC, USA, 27713
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.

Chimerix Headlines

No Headlines